Scott North

Scott North

UNVERIFIED PROFILE

Are you Scott North?   Register this Author

Register author
Scott North

Scott North

Publications by authors named "Scott North"

Are you Scott North?   Register this Author

100Publications

3243Reads

14Profile Views

Eligibility Criteria and Endpoints in Metastatic Renal Cell Carcinoma Trials.

Am J Clin Oncol 2020 May 8. Epub 2020 May 8.

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000705DOI Listing
May 2020

Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer.

Urol Oncol 2020 Feb 11. Epub 2020 Feb 11.

Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX; Departments of Urology, Weill Cornell Medical College, New York, New York; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2020.01.010DOI Listing
February 2020

Cost-effectiveness analysis of metformin with enzalutamide in the metastatic castrate-resistant prostate cancer setting.

Can J Urol 2019 Dec;26(6):10045-10053

Department of Radiation Oncology, University of Alberta, Edmonton, Alberta, Canada.

View Article

Download full-text PDF

Source
December 2019

Real world evidence: Abiraterone use post-docetaxel in metastatic castrate-resistant prostate cancer.

J Oncol Pharm Pract 2019 Sep 27;25(6):1293-1300. Epub 2018 Jun 27.

1 Tom Baker Cancer Center, Calgary, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155218784716DOI Listing
September 2019

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.

N Engl J Med 2019 07 2;381(2):121-131. Epub 2019 Jun 2.

From Monash University (I.D.D., M.F., D.W.P.), Eastern Health (I.D.D.), Australian Urology Associates (M.F.), Monash Health (D.W.P.), and the Peter MacCallum Cancer Centre and the University of Melbourne (S.K.S., S.G.W.), Melbourne, VIC, the National Health and Medical Research Council Clinical Trials Centre, University of Sydney (A.J.M., M.R.S., X.C., W.E.H., E.T., S.Y., A.Y.Z.), the Chris O'Brien Lifehouse (M.R.S., L.G.H., A.Y.Z.), the University of Sydney (L.G.H., G.M.), Royal Prince Alfred Hospital (L.G.H.), Kinghorn Cancer Centre, St. Vincent's Hospital, and Garvan Institute of Medical Research (A.M.J.), Macquarie University (A.Y.Z.), and Western Sydney University (R.R.Z.), Sydney, Concord Cancer Centre, Concord Repatriation General Hospital, Concord, NSW (M.R.S.), Port Macquarie Base Hospital and Mid North Coast Cancer Institute Port Macquarie, Port Macquarie, NSW (S.B.), Sydney Adventist Hospital, Wahroonga, NSW (G.M.), the ANZUP Cancer Trials Group, Camperdown, NSW (M.M.), the Adelaide Cancer Centre and the University of Adelaide (F.P.) and the Royal Adelaide Hospital (T.H.T.), Adelaide, SA, and Orange Health Service, Central West Cancer Care Centre, Orange, NSW (R.R.Z.) - all in Australia; BC Cancer and the University of British Columbia, Vancouver (K.N.C.), the Cross Cancer Institute and the University of Alberta, Edmonton (S.A.N.), Canadian Cancer Trials Group, Queen's University (W.P., F.V.-B.), and the Kingston Health Sciences Center (F.V.-B.), Kingston, ON, and the University of Ottawa and the Ottawa Hospital Research Institute, Ottawa (M.N.R.) - all in Canada; Guy's and St. Thomas' NHS Foundation Trust Biomedical Research Centre, Cancer Research UK and King's College London, and Sarah Cannon Research UK, London (S.C.), and the Royal Cornwall Hospital, Truro (A. Thomson) - all in the United Kingdom; Auckland City Hospital, Auckland (N.J.L.), and the Waikato District Health Board, Hamilton (A. Tan) - both in New Zealand; Cancer Trials Ireland (J.M., R.M.), Mater Misericordiae University Hospital (J.M.), and St. Vincent's University Hospital and University College Dublin (R.M.D.) - all in Dublin; and Dana-Farber Cancer Institute and Harvard Medical School (C.J.S.) - both in Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1903835DOI Listing
July 2019

Real-world Outcomes in Advanced Urothelial Cancer and the Role of Neutrophil to Lymphocyte Ratio.

Clin Genitourin Cancer 2018 06 29;16(3):e637-e644. Epub 2017 Dec 29.

Tom Baker Cancer Centre, Department of Oncology, University of Calgary, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.12.009DOI Listing
June 2018

Effects of high-intensity interval training on fatigue and quality of life in testicular cancer survivors.

Br J Cancer 2018 05 8;118(10):1313-1321. Epub 2018 May 8.

Faculty of Kinesiology, Sport, and Recreation, University of Alberta, Edmonton, AB, T6G 2H9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0044-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959855PMC
May 2018

Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer.

J Clin Oncol 2017 Oct 20;35(28):3181-3188. Epub 2017 Jun 20.

Emmanuel S. Antonarakis and Mario A. Eisenberger, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Scott T. Tagawa, Giuseppe Galletti, Daniel Worroll, Karla Ballman, Ada Gjyrezi, Shinsuke Tasaki, Luigi Portella, Yang Bai, Brian J. Kirby, David M. Nanus, and Paraskevi Giannakakou, Weill Cornell Medicine/Meyer Cancer Center; Che-Kai Tsao, Mount Sinai Medical Center, New York; Timothy B. Lannin, Shalu Suri, Conor N. Gruber, Erica D. Pratt, and Brian J. Kirby, Cornell University, Ithaca, NY; Marie Vanhuyse, Medical Oncology, Montréal General Hospital; Fred Saad, University of Montreal Hospital Center, Montreal; John Stewart, Atef Zaher, and Wei Zhou, Sanofi, Laval, Quebec, Canada; Guru Sonpavde, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; Scott North, University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada; Costantine Albany, Indiana University School of Medicine, Indianapolis, IN; and Ted Szatrowski, Sanofi, Bridgewater, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.4138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791829PMC
October 2017

The role of the built environment in a randomized controlled trial to increase physical activity among men with prostate cancer: the PROMOTE trial.

Support Care Cancer 2017 10 27;25(10):2993-2996. Epub 2017 Jun 27.

Faculty of Physical Education and Recreation, 1-113 University Hall, Van Vliet Complex, University of Alberta, Edmonton, AB, T6G 2H9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-017-3798-1DOI Listing
October 2017

Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors: A phase 2 randomized controlled trial.

Cancer 2017 Oct 14;123(20):4057-4065. Epub 2017 Jul 14.

Faculty of Physical Education and Recreation, University of Alberta, Edmonton, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30859DOI Listing
October 2017

Screen Failure Rates in Contemporary Randomized Clinical Phase II/III Therapeutic Trials in Genitourinary Malignancies.

Clin Genitourin Cancer 2017 Sep 8. Epub 2017 Sep 8.

Princess Margaret Cancer Centre, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15587673173027
Publisher Site
http://dx.doi.org/10.1016/j.clgc.2017.08.019DOI Listing
September 2017

Sunitinib maintenance therapy after response to docetaxel in metastatic castration resistant prostate cancer (mCRPC).

Invest New Drugs 2016 12 26;34(6):771-776. Epub 2016 Aug 26.

Department of Medical Oncology, BC Cancer Agency, Vancouver Cancer Centre, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-016-0386-zDOI Listing
December 2016

Feasibility and preliminary efficacy of adding behavioral counseling to supervised physical activity in kidney cancer survivors: a randomized controlled trial.

Cancer Nurs 2014 Sep-Oct;37(5):E8-22

Author Affiliations: Faculty of Physical Education and Recreation, University of Alberta, Edmonton, Canada (Drs Trinh and Courneya); Priority Research Centre in Physical Activity and Nutrition, The University of Newcastle, Callaghan, Australia (Dr Plotnikoff); Faculty of Education, University of Victoria, Canada (Dr Rhodes); and Department of Medicine, Cross Cancer Institute, Edmonton, Canada (Dr North).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/NCC.0b013e3182a40fb6DOI Listing
July 2016

Assessing the utility of cabazitaxel in mCRPC.

Authors:
Scott A North

Can Urol Assoc J 2016 Mar-Apr;10(3-4):111-2

Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5489/cuaj.3721DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839991PMC
May 2016

Social-ecological correlates of physical activity in kidney cancer survivors.

J Cancer Surviv 2016 Feb 6;10(1):164-75. Epub 2015 Jun 6.

Faculty of Physical Education and Recreation, University of Alberta, Edmonton, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2Fs11764-015-04
Web Search
http://link.springer.com/10.1007/s11764-015-0462-y
Publisher Site
http://dx.doi.org/10.1007/s11764-015-0462-yDOI Listing
February 2016

Changes in motivational outcomes following a supervised physical activity program with behavioral counseling in kidney cancer survivors: a pilot study.

Psychooncology 2015 Sep 27;24(9):1204-7. Epub 2015 Jan 27.

Faculty of Physical Education and Recreation, University of Alberta, Edmonton, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.3754DOI Listing
September 2015

Perioperative chemotherapy for muscle invasive bladder cancer.

Curr Opin Support Palliat Care 2015 Sep;9(3):249-54

aDivision of Urology, Department of Surgery bDivision of Medical Oncology, Department of Oncology, University of Alberta, Edmonton, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SPC.0000000000000148DOI Listing
September 2015

Intermittent LHRH therapy in the management of castrate-resistant prostate cancer (CRPCa): results of a multi-institutional randomized prospective clinical trial.

Am J Clin Oncol 2013 Dec;36(6):601-5

Departments of *Urology †Medicine and Urology ‡Radiation Oncology §Atlantic Clinical Cancer Research Unit (ACCRU), Capital Health #Medicine **Urology, Centre for Clinical Research, Dalhousie University, Halifax, NS ∥Department of Medical Oncology, University of Calgary, Tom Baker Cancer Center, Calgary ¶Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, AB, Canada.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/COC.0b013e31825d5664DOI Listing
December 2013

Randomized controlled trial of a behavior change intervention to increase physical activity and quality of life in prostate cancer survivors.

Ann Behav Med 2013 Dec;46(3):382-93

School of Human Kinetics and Recreation, Memorial University of Newfoundland, Physical Education Building (PE 2022B), A1C 5S7, St. John's, NL, Canada,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12160-013-9519-1DOI Listing
December 2013

Physical activity preferences in a population-based sample of kidney cancer survivors.

Support Care Cancer 2012 Aug 24;20(8):1709-17. Epub 2011 Sep 24.

Faculty of Physical Education and Recreation, University of Alberta, Edmonton, AB, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00520-011-1264-z
Publisher Site
http://dx.doi.org/10.1007/s00520-011-1264-zDOI Listing
August 2012

Correlates of physical activity in a population-based sample of kidney cancer survivors: an application of the theory of planned behavior.

Int J Behav Nutr Phys Act 2012 Aug 6;9:96. Epub 2012 Aug 6.

Faculty of Physical Education and Recreation, University of Alberta, Edmonton, Edmonton, Alberta, T6G 2H9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5868-9-96DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489870PMC
August 2012

Associations between physical activity and quality of life in a population-based sample of kidney cancer survivors.

Cancer Epidemiol Biomarkers Prev 2011 May 5;20(5):859-68. Epub 2011 Apr 5.

Faculty of Physical Education and Recreation, University of Alberta, Edmonton, Alberta, Canada.

View Article

Download full-text PDF

Source
http://cebp.aacrjournals.org/cgi/doi/10.1158/1055-9965.EPI-1
Publisher Site
http://dx.doi.org/10.1158/1055-9965.EPI-10-1319DOI Listing
May 2011

A phase II trial of weekly i.v. KW-2170 in advanced castrate-resistant prostate cancer.

Asia Pac J Clin Oncol 2010 Dec 3;6(4):292-7. Epub 2010 Nov 3.

St George Hospital Cancer Care Centre, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1743-7563.2010.01328.xDOI Listing
December 2010

A rapid PSA half-life following docetaxel chemotherapy is associated with improved survival in hormone refractory prostate cancer.

Can Urol Assoc J 2009 Oct;3(5):369-74

Department of Internal Medicine, University of Alberta, Edmonton, AB;

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2758517PMC
http://dx.doi.org/10.5489/cuaj.1145DOI Listing
October 2009

A prospective study of the determinants of exercise in bladder cancer survivors using the Theory of Planned Behavior.

Support Care Cancer 2009 Feb 6;17(2):171-9. Epub 2008 Jun 6.

Faculty of Physical Education & Recreation, University of Alberta, Edmonton, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-008-0471-8DOI Listing
February 2009

Dr. North's rebuttal.

Authors:
Scott North

Can Urol Assoc J 2008 Jun;2(3):228

Associate Professor, Department of Oncology, University of Alberta, Edmonton, Atla., Medical Oncologist, Cross Cancer Institute, Edmonton, Alta.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494890PMC
June 2008

Why consider neoadjuvant chemotherapy for muscle-invasive transitional cell carcinoma of the bladder?

Authors:
Scott North

Can Urol Assoc J 2008 Jun;2(3):222-4

Associate Professor, Department of Oncology, University of Alberta, and Medical Oncologist, Cross Cancer Institute, Edmonton, Alta.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2494892PMC
http://dx.doi.org/10.5489/cuaj.602DOI Listing
June 2008

L-BLP25: a MUC1-targeted peptide vaccine therapy in prostate cancer.

Expert Opin Biol Ther 2007 Nov;7(11):1723-30

Cross Cancer Institute, Department of Medical Oncology, 11560 University Avenue, Edmonton, Alberta, T6G 1H7, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.7.11.1723DOI Listing
November 2007

Associations between exercise and quality of life in bladder cancer survivors: a population-based study.

Cancer Epidemiol Biomarkers Prev 2007 May;16(5):984-90

Faculty of Physical Education and Recreation, University of Alberta, E-488 Van Vliet Center, Edmonton, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-06-0680DOI Listing
May 2007

Malignant spinal cord compression secondary to testicular seminoma at the time of initial presentation and at relapse while on surveillance.

Can Urol Assoc J 2007 Mar;1(1):59-63

Department of Oncology, and Division of Radiology, Cross Cancer Institute, Edmonton, Alta.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2422929PMC
http://dx.doi.org/10.5489/cuaj.41DOI Listing
March 2007

Exercise programming and counseling preferences in bladder cancer survivors: a population-based study.

J Cancer Surviv 2007 Mar;1(1):27-34

Faculty of Physical Education and Recreation, University of Alberta, E-488, Van Vliet Center, Edmonton, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11764-007-0010-5DOI Listing
March 2007

Prostate-specific antigen doubling time is associated with survival in men with hormone-refractory prostate cancer.

Urology 2006 Sep;68(3):565-9

University of Alberta Faculty of Medicine, Edmonton, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2006.03.055DOI Listing
September 2006

Vaccination with BLP25 liposome vaccine to treat non-small cell lung and prostate cancers.

Expert Rev Vaccines 2005 Jun;4(3):249-57

Cross Cancer Institute, 11560 University Avenue, Edmonton, Alberta T6G 1Z2, Canada.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14760584.4.3.249
Publisher Site
http://dx.doi.org/10.1586/14760584.4.3.249DOI Listing
June 2005

Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study.

Thromb Res 2003 ;112(1-2):59-64

Department of Medical Oncology, Cross Cancer Institute and Department of Oncology, University of Alberta, Edmonton, AB, Canada T6G 2H7.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2003.10.012DOI Listing
June 2004